The five-year recurrence-free survival rates for women with EEC are favorable, ranging from 68% to 83.1% [19,21–23], reflecting the fact that EEC can frequently be cured by surgical intervention [17,24]. Nonetheless, high-grade (G3) EECs have significantly poorer prognosis than lower ...
The prognosis in uterine sarcomas is significantly worse than epithelial endometrial cancer of comparable stage. In one study 5-year survivals of 75.8% for stage I, 60.1% for stage II, 44.9% stage III and 28.7% for stage IV were described. Low-grade ESS have a 5-year survival of 80% bu...
The significantly better prognosis of the carcinosarcoma patients supports the opinion that subclassification of these types of neoplasms has practical value. The survival rate for both groups of tumors is influenced by the degree of myometrial invasion and the patient's age; these 2 ...
Uterine sarcomas: natural history, treatment and prognosis. Cancer. 1978;42:1152–60. Article CAS PubMed Google Scholar Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein ML, Dunne ME, et al. Uterine sarcomas. Analysis of failures with special emphasis on the use of adjuvant ...
carcinosarcomasandtheprognosisjsverypoor. Keywords cervixneoplasms;radiotherapy;uterineneoplasms;secondneoplasms Radiationtherapyisthestandardtreatmentformost patientswithstagesIIb-IVacenricalcancer.Recentran— domizedtrialsdemonstratingimprovedsurvivalwhen concurrentchemotherapyisaddedtoradiationhaveled ...
overall survival (OS)quantitative polymerase chain reaction (Q-PCR)relapse-free survival (RFS)Uterine serous papillary carcinoma (USPC) are high-grade tumors with Her2 gene expression and poor prognosis. The human gene Her2 is a proto-oncogene that encodes a protein with tyrosine kinase activity....
Cancer biomarkers are commonly used in pediatrics to monitor cancer progression, recurrence, and prognosis, but pediatric reference value distributions have not been well established so far. The normal range of AFP in an adult is below 20 ng/mL, while CA125 is below 35 U/mL. The Canadian ...
PrognosisPurpose To determine the survival outcomes, prognostic factors, and patterns of failure in patients with malignant mixed M眉llerian tumor (MMMT) of the uterus. Methods and materials Between 1954 and 1998, 300 patients with clinical Stage I鈥揑II MMMT of the uterus were treated with ...
Patients with stromal sarcoma presented with 55% survival rate within five years. The authors stated that the “size of the primary tumor and presence of vein invasion showed a slight correlation with the patient’s prognosis but no correlation was found with increasing degrees of cellular atypi...
Patients with stromal sarcoma presented with 55% survival rate within five years. The authors stated that the "size of the primary tumor and presence of vein invasion showed a slight correlation with the patient's prognosis but no correlation was found with increasing degrees of cellular atypism...